Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study

Autor: Zare-Zardini H, Alemi A, Taheri-Kafrani A, Hosseini SA, Soltaninejad H, Hamidieh AA, Haghi Karamallah M, Farrokhifar M

Publikováno v: Drug Design, Development and Therapy, Vol Volume 14, Pp 3315-3324 (2020)

Hadi Zare-Zardini,1– 3 Ashraf Alemi,4 Asghar Taheri-Kafrani,5 Seyed Ahmad Hosseini,6 Hossein Soltaninejad,7,8 Amir Ali Hamidieh,9 Mojtaba Haghi Karamallah,10 Majid Farrokhifar,11 Mohammad Farrokhifar12 1Hematology and Oncology Research Center, Shah

Externí odkaz: https://doaj.org/article/4252b1057dd94e35906ad916ce1f510d

Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends

Autor: Baldomero, H, Aljurf, M, Zaidi, SZA, Hashmi, SK, Ghavamzadeh, A, Elhaddad, A, Hamladji, R-M, Ahmed, P, Torjemane, L, Abboud, M, Tbakhi, A, Khabori, MA, El Quessar, A, Bazuaye, N, Bekadja, MA, Adil, S, Fahmy, O, Ramzi, M, Ibrahim, A, Alseraihy, A, Ben Abdejalil, N, Sarhan, M, Huneini, MA, Mahmal, L, ElSolh, H, Hussain, F, Nassar, A, Al-Hashmi, H, Hamidieh, AA, Pasquini, M, Kodera, Y, Kröger, N, Mohty, M, Jaimovich, G, Rolon, JM, Paulson, K, Greinix, H, Weisdorf, D, Horowitz, M, Nunez, J, Gratwohl, A, Passweg, J, Koh, M, Szer, J, Niederwieser, D, Novitzky, N, East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow

Hematopoietic Stem Cell Transplantation (HSCT) activity was evaluated in the African (AFR)/EMRO region and compared to the global activity for the years 2006-2013. Data were obtained from 1570 teams in the 6 WHO continental regions. Of these, 29 (1.8

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::8ad3edcb6c7d5764bd9dff2c8d42ac0c
https://openaccess.sgul.ac.uk/id/eprint/113884/1/nihms-1004117.pdf

Prevention and Control of Infections in Patients with Severe Congenital Neutropenia; A Follow up Study.

Autor: Salehi T, Fazlollahi MR, Maddah M, Nayebpour M, Tabatabaei Yazdi M, Alizadeh Z, Eshghi P, Chavoshzadeh Z, Movahedi M, Hamidieh AA, Cheraghi T, Pourpak Z, Moin M

Publikováno v: Iranian Journal of Allergy, Asthma & Immunology; 2012, Vol. 11 Issue 1, p51-56, 6p

Hematopoietic Stem Cell Transplantation for C1q Deficiency: A Study on Behalf of the EBMT Inborn Errors Working Party.

Autor: Buso H; Department of Medicine (DIMED), University of Padova, Padua, Italy.; Paediatric Haematopoietic Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle Upon Tyne, NE1 4LP, UK., Adam E; Sheba Medical Center, The Edmond and Lily Safra Children's Hospital, Ramat Gan, Israel., Arkwright PD; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK., Bhattad S; Division of Paediatric Immunology and Rheumatology, Department of Paediatrics, Aster CMI Hospital, Bengaluru, India., Hamidieh AA; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Behfar M; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Belot A; Department of Paediatric Rheumatology, Femme-Mère-Enfant Hospital, HCL, Lyon, France., Benezech S; Institute of Hematology and Pediatric Oncology, 69008, Lyon, France., Chan AY; Division of Pediatric Allergy, Immunology, and Blood and Marrow Transplant, UCSF Benioff Children's Hospital, University of California San Francisco, San Francisco, CA, USA., Crow YJ; Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France.; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Dvorak CC; Division of Pediatric Allergy, Immunology, and Blood and Marrow Transplant, UCSF Benioff Children's Hospital, University of California San Francisco, San Francisco, CA, USA., Flinn AM; Department of Pediatric Immunology, Children's Health Ireland at Crumlin, Dublin, Ireland., Kapoor U; Division of of Pediatrics Haematology, Oncology and Stem Cell Transplant, Children's Hospital New York-Presbyterian, Columbia University, 161 Fort Washington, Irving 7, New York, NY, 10032, USA., Lankester A; Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands., Kobayashi M; Department of Pediatrics, Hiroshima University Hospital, 1‑2‑3 Kasumi, Minami‑ku, Hiroshima, 734‑8551, Japan., Matsumura R; Department of Pediatrics, Hiroshima University Hospital, 1‑2‑3 Kasumi, Minami‑ku, Hiroshima, 734‑8551, Japan., Mottaghipisheh H; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Okada S; Department of Pediatrics, Hiroshima University Hospital, 1‑2‑3 Kasumi, Minami‑ku, Hiroshima, 734‑8551, Japan., Ouachee M; Institute of Hematology and Pediatric Oncology, 69008, Lyon, France., Parvaneh N; Division of Allergy and Clinical Immunology, Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran., Ramprakash S; Aster International Institute of Oncology, Aster CMI Hospital, Bangalore, India., Satwani P; Division of of Pediatrics Haematology, Oncology and Stem Cell Transplant, Children's Hospital New York-Presbyterian, Columbia University, 161 Fort Washington, Irving 7, New York, NY, 10032, USA., Sharafian S; Department of Allergy and Clinical Immunology, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Triaille C; Pôle de Pathologies Rhumatismales Systémiques Et Inflammatoires, Institut de Recherche Expérimentale Et Clinique, Université Catholique de Louvain, Brussels, Belgium.; Pediatric Immunology and Rheumatology Division, Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada., Wynn RF; Department of Paediatric Haematology & Oncology, Royal Manchester Children's Hospital, Manchester, UK., Movahedi N; Golestan Rheumatology Research Center (GRRC), Golestan University of Medical Sciences, Gorgan, Iran.; Pediatric Rheumatology Research Group, Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran., Ziaee V; Pediatric Rheumatology Research Group, Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran., Williams E; Paediatric Haematopoietic Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle Upon Tyne, NE1 4LP, UK., Slatter M; Paediatric Haematopoietic Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle Upon Tyne, NE1 4LP, UK.; Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Gennery AR; Paediatric Haematopoietic Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle Upon Tyne, NE1 4LP, UK. andrew.gennery@newcastle.ac.uk.; Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK. andrew.gennery@newcastle.ac.uk.

Publikováno v: Journal of clinical immunology [J Clin Immunol] 2024 Oct 29; Vol. 45 (1), pp. 35. Date of Electronic Publication: 2024 Oct 29.

Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation.

Autor: Mohseni R; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Mahdavi Sharif P; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Behfar M; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Shojaei S; National Institute of Genetic Engineering and Biotechnology, Tehran, Iran., Shoae-Hassani A; Stem Cell and Regenerative Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran., Jafari L; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Khosravi A; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Nikfetrat Z; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Hamidieh AA; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran. aahamidieh@tums.ac.ir.

Publikováno v: Scientific reports [Sci Rep] 2024 Sep 09; Vol. 14 (1), pp. 20971. Date of Electronic Publication: 2024 Sep 09.